Chile · Delayed Price · Currency is CLP Oxiquim Statistics
Total Valuation
Oxiquim has a market cap or net worth of CLP 286.20 billion. The enterprise value is 330.33 billion.
| Market Cap | 286.20B |
| Enterprise Value | 330.33B |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jul 28, 2025 |
Share Statistics
Oxiquim has 24.89 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 24.89M |
| Shares Outstanding | 24.89M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | n/a |
| Float | 1.45M |
Valuation Ratios
The trailing PE ratio is 10.52.
| PE Ratio | 10.52 |
| Forward PE | n/a |
| PS Ratio | 1.19 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | 13.84 |
| P/OCF Ratio | 8.30 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.60, with an EV/FCF ratio of 15.98.
| EV / Earnings | 12.14 |
| EV / Sales | 1.37 |
| EV / EBITDA | 7.60 |
| EV / EBIT | 9.82 |
| EV / FCF | 15.98 |
Financial Position
The company has a current ratio of 1.32, with a Debt / Equity ratio of 0.54.
| Current Ratio | 1.32 |
| Quick Ratio | 0.89 |
| Debt / Equity | 0.54 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 3.25 |
| Interest Coverage | 13.66 |
Financial Efficiency
Return on equity (ROE) is 23.11% and return on invested capital (ROIC) is 11.60%.
| Return on Equity (ROE) | 23.11% |
| Return on Assets (ROA) | 8.83% |
| Return on Invested Capital (ROIC) | 11.60% |
| Return on Capital Employed (ROCE) | 18.37% |
| Revenue Per Employee | 567.52M |
| Profits Per Employee | 64.18M |
| Employee Count | 430 |
| Asset Turnover | 1.01 |
| Inventory Turnover | 7.10 |
Taxes
In the past 12 months, Oxiquim has paid 9.51 billion in taxes.
| Income Tax | 9.51B |
| Effective Tax Rate | 25.89% |
Stock Price Statistics
The stock price has increased by +47.44% in the last 52 weeks. The beta is 0.10, so Oxiquim's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +47.44% |
| 50-Day Moving Average | 10,607.01 |
| 200-Day Moving Average | 9,265.13 |
| Relative Strength Index (RSI) | 98.77 |
| Average Volume (20 Days) | 124 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Oxiquim had revenue of CLP 240.63 billion and earned 27.21 billion in profits. Earnings per share was 1,093.40.
| Revenue | 240.63B |
| Gross Profit | 79.10B |
| Operating Income | 33.62B |
| Pretax Income | 36.72B |
| Net Income | 27.21B |
| EBITDA | 42.80B |
| EBIT | 33.62B |
| Earnings Per Share (EPS) | 1,093.40 |
Balance Sheet
The company has 23.08 billion in cash and 67.21 billion in debt, giving a net cash position of -44.13 billion or -1,773.32 per share.
| Cash & Cash Equivalents | 23.08B |
| Total Debt | 67.21B |
| Net Cash | -44.13B |
| Net Cash Per Share | -1,773.32 |
| Equity (Book Value) | 123.45B |
| Book Value Per Share | 4,960.51 |
| Working Capital | 21.29B |
Cash Flow
In the last 12 months, operating cash flow was 34.47 billion and capital expenditures -13.80 billion, giving a free cash flow of 20.67 billion.
| Operating Cash Flow | 34.47B |
| Capital Expenditures | -13.80B |
| Free Cash Flow | 20.67B |
| FCF Per Share | 830.64 |
Margins
Gross margin is 32.87%, with operating and profit margins of 13.97% and 11.31%.
| Gross Margin | 32.87% |
| Operating Margin | 13.97% |
| Pretax Margin | 15.26% |
| Profit Margin | 11.31% |
| EBITDA Margin | 17.79% |
| EBIT Margin | 13.97% |
| FCF Margin | 8.59% |
Dividends & Yields
This stock pays an annual dividend of 704.00, which amounts to a dividend yield of 6.12%.
| Dividend Per Share | 704.00 |
| Dividend Yield | 6.12% |
| Dividend Growth (YoY) | -28.55% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 59.01% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 6.12% |
| Earnings Yield | 9.51% |
| FCF Yield | 7.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Oxiquim has an Altman Z-Score of 2.92 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 6 |